Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2023
About
Suggestions
Contact Us
meglumine-eicosapentaenoic acid formulation
MeSH Supplementary Concept Data 2024
Details
Concepts
MeSH Supplementary
meglumine-eicosapentaenoic acid formulation
Unique ID
C517011
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C517011
Entry Term(s)
MeEPA formulation
Registry Number
0
Heading Mapped to
Drug Combinations
*Meglumine
*Eicosapentaenoic Acid
Frequency
1
Note
a soluble omega-3 fatty acid formulation that acts synergistically with epirubicin and mitomycin to enhance cytotoxicity towards bladder cancer cell lines
Source
Prostaglandins Leukot Essent Fatty Acids 2006 Dec;75(6):367-73
Date of Entry
2007/02/09
Expand All
Collapse All
meglumine-eicosapentaenoic acid formulation
Preferred
Concept UI
M0506560
Registry Number
0
Terms
meglumine-eicosapentaenoic acid formulation
Preferred Term
Term UI
T691322
Date
02/09/2007
LexicalTag
NON
ThesaurusID
NLM (2007)
MeEPA formulation
Term UI
T691323
Date
02/09/2007
LexicalTag
NON
ThesaurusID
NLM (2007)
page delivered in 0.003s